Brief: Vista Pharmaceuticals Enters Joint Venture With Pleiades Therapeutics
03/02/2026 09:41
Feb 3 (Reuters) - Vista Pharmaceuticals Ltd VIPH.BO: ENTERS JOINT VENTURE WITH PLEIADES THERAPEUTICS JOINT VENTURE TO DEVELOP GENERIC AND SPECIALTY PHARMACEUTICAL PRODUCTS Source text: ID:nBSE13gcRR Further company coverage: VIPH.BO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vista Pharmaceuticals
See all newsBrief: Vista Pharmaceuticals Enters Joint Venture With Pleiades Therapeutics
Brief: Vista Pharmaceuticals To Issue 48.9 Million Warrants At 12 Rupees Each
Brief: Vista Pharmaceuticals To Issue Upto 17.4 Million Shares At Rupees 12.96 Each On Preferential Basis
Brief: Vista Pharmaceuticals To Consider Proposal For Raising Funds By Way Of Issue Of Preferential Issue Of Shares
Brief: Vista Pharmaceuticals Names Dhananjaya Alli As Chairman